Nukkleus Statistics
Total Valuation
Nukkleus has a market cap or net worth of $12.89 million. The enterprise value is $12.55 million.
Market Cap | 12.89M |
Enterprise Value | 12.55M |
Important Dates
The next estimated earnings date is Wednesday, May 15, 2024, after market close.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Nukkleus has 13.90 million shares outstanding. The number of shares has decreased by -65.03% in one year.
Shares Outstanding | 13.90M |
Shares Change (YoY) | -65.03% |
Shares Change (QoQ) | -1.72% |
Owned by Insiders (%) | 9.76% |
Owned by Institutions (%) | 1.56% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.48 |
Forward PS | n/a |
PB Ratio | 1.61 |
P/FCF Ratio | 6.18 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 6.02 |
Financial Position
The company has a current ratio of 0.33, with zero debt.
Current Ratio | 0.33 |
Quick Ratio | 0.09 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -445.20% and return on invested capital (ROIC) is -90.23%.
Return on Equity (ROE) | -445.20% |
Return on Assets (ROA) | -109.30% |
Return on Capital (ROIC) | -90.23% |
Revenue Per Employee | $2.23M |
Profits Per Employee | -$1.01M |
Employee Count | 12 |
Asset Turnover | 2.41 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | -0.29 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.97 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 49.43 |
Average Volume (30 Days) | 990,398 |
Short Selling Information
The latest short interest is 210,200, so 1.51% of the outstanding shares have been sold short.
Short Interest | 210,200 |
Short Previous Month | 476,905 |
Short % of Shares Out | 1.51% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, Nukkleus had revenue of $26.73 million and -$12.10 million in losses. Loss per share was -$0.24.
Revenue | 26.73M |
Gross Profit | -819,414 |
Operating Income | -7.21M |
Pretax Income | -12.10M |
Net Income | -12.10M |
EBITDA | -7.63M |
EBIT | -12.10M |
Loss Per Share | -$0.24 |
Balance Sheet
The company has $332,598 in cash and no debt, giving a net cash position of $332,598 or $0.02 per share.
Cash & Cash Equivalents | 332,598 |
Total Debt | n/a |
Net Cash | 332,598 |
Net Cash Per Share | $0.02 |
Equity / Book Value | 7.99M |
Book Value Per Share | 0.57 |
Working Capital | -4.96M |
Cash Flow
In the last 12 months, operating cash flow was $2.13 million and capital expenditures -$41,706, giving a free cash flow of $2.08 million.
Operating Cash Flow | 2.13M |
Capital Expenditures | -41,706 |
Free Cash Flow | 2.08M |
FCF Per Share | $1.09 |
Margins
Gross margin is -3.07%, with operating and profit margins of -26.96% and -45.27%.
Gross Margin | -3.07% |
Operating Margin | -26.96% |
Pretax Margin | -45.27% |
Profit Margin | -45.27% |
EBITDA Margin | -28.55% |
EBIT Margin | -45.27% |
FCF Margin | 7.80% |
Dividends & Yields
Nukkleus does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 65.03% |
Shareholder Yield | 65.03% |
Earnings Yield | -93.90% |
FCF Yield | 16.17% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 26, 2023. It was a forward split with a ratio of 140:100.
Last Split Date | Dec 26, 2023 |
Split Type | Forward |
Split Ratio | 140:100 |
Scores
Nukkleus has an Altman Z-Score of -1.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.79 |
Piotroski F-Score | 4 |